Filter
1228
Filtered Results: 1228
Text search:
in
vitro
Featured
Recommendations
146
New Publications
216
Language
Document type
No document type
473
Guidelines
358
Studies & Reports
198
Manuals
90
Fact sheets
51
Strategic & Response Plan
34
Training Material
12
Situation Updates
6
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
41
Brazil
41
Russia
36
India
31
Global
29
Colombia
25
Germany
25
South Africa
21
Paraguay
20
Argentina
17
Western and Central Europe
15
Mozambique
14
Africa
14
Venezuela
14
Sierra Leone
13
Bolivia
12
Angola
12
Peru
11
Ethiopia
10
Kenya
9
Middle East and North Africa
9
Ukraine
8
Rwanda
8
Cameroon
8
Burkina Faso
8
Eastern Europe
8
Zambia
8
Myanmar / Burma
8
Philippines
7
Tanzania
7
Spain
7
Uganda
7
Indonesia
7
Liberia
7
El Salvador
6
Syria
6
Nigeria
6
Eastern Europe and Central Asia
6
Namibia
6
Yemen
6
Chile
5
Guinea
5
West and Central Africa
5
South–East Asia Region
5
Ecuador
5
Senegal
4
Malawi
4
Italy
4
Haiti
4
Guinea-Bissau
4
France
4
Bangladesh
4
Nepal
3
Lesotho
3
Benin
3
Congo-Brazzaville
3
Niger
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Mali
3
Eswatini/ Swaziland
3
Tajikistan
2
Ghana
2
Kazakhstan
2
Asia
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Sudan
2
Honduras
2
Chad
2
South Sudan
2
Madagascar
2
Guatemala
2
North Macedonia
1
Thailand
1
Mexico
1
Serbia
1
Turkey
1
Gambia
1
Togo
1
Albania
1
Canada
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Zimbabwe
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
USA
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
North America
1
Belgium
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Libya
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
403
Clinical Guidelines
171
Pharmacy & Technologies
56
Women & Child Health
37
Public Health
36
Key Resources
27
Capacity Building
3
Toolboxes
COVID-19
271
TB
129
HIV
115
NTDs
84
AMR
58
Ebola & Marburg
47
Rapid Response
44
Pharmacy
37
Zika
31
Planetary Health
27
Mental Health
19
Caregiver
19
Refugee
18
Malaria
14
Global Health Education
12
Health Financing Toolbox
6
NCDs
6
Conflict
6
Polio
6
Specific Hazards
5
Natural Hazards
4
Cholera
4
Disability
3
Social Ethics
1
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
orientaciones provisionales, 8 de noviembre de 2020
This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e...
This second edition of the “living paper” contributes to the global knowledge on how countries are responding to the pandemic by documenting real-time actions in a key area of response – that is, social protection measures planned or implemented by governments.
For the purpose of this revie...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной...
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility...
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
